Form 4 holding
Director
SOLIGENIX, INC.
- Security class
- Common Stock
- Shares / value
- 25,317
- Estimated value
- $11,223
- Report date
- 03 May 2023
- Price
- $0.4433
- Ownership
- Silk Road Therapeutics, Inc.
Timothy R. Cote
Insider Reports History
- Reporting-owner location
- Washington, DC
- Latest reporting-owner signature
- /s/ Timothy R. Cote
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Timothy R. Cote
Form 4 holding
Director
SOLIGENIX, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 15,000
- Estimated value
- Report date
- 03 May 2023
- Price
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
Insider Reports Filed by Timothy R. Cote
4
SNGX
SOLIGENIX, INC.
- Report period
- 03 May 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 05 May 2023, 18:38
- Role
- Director
- Next action
- Open filing details
3
SNGX
SOLIGENIX, INC.
- Report period
- 03 May 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 05 May 2023, 18:25
- Role
- Director
- Next action
- Open filing details